<strong>Simvastatin in combination with bevacizumab inhibits the proliferation, migration and invasion while promotes the apoptosis of pulmonary adenocarcinoma A549 cells via HIF-1α-Wnt/β-catenin pathway</strong>

doi:10.3781/j.issn.1000-7431.2022.2107-0475

PDF(2247 KB)

Tumor ›› 2022, Vol. 42 ›› Issue (04) : 229-240. DOI: 10.3781/j.issn.1000-7431.2022.2107-0475

Simvastatin in combination with bevacizumab inhibits the proliferation, migration and invasion while promotes the apoptosis of pulmonary adenocarcinoma A549 cells via HIF-1α-Wnt/β-catenin pathway

{{article.zuoZhe_EN}}

Author information +

History +

HeighLight

Abstract

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2022, 42(04): 229-240 https://doi.org/10.3781/j.issn.1000-7431.2022.2107-0475

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

Funding

RIGHTS & PERMISSIONS

PDF(2247 KB)

Accesses

Citation

Detail

Sections

Recommended

Received	Accepted	Published
2021-07-12	2021-10-18	2022-04-25
Issue Date
2022-04-25

Please choose a citation manager

Content to export

HeighLight

Abstract

Key words

QR code of this article

Cite this article

{{custom_sec.title}}

{{custom_sec.title}}

References

References

{{custom_fnGroup.title_en}}

Footnotes

{{custom_ack.title_en}}

Funding

RIGHTS & PERMISSIONS